Shore Capital Partnershas closed a $112.5 million health care-focused private equity fund. Shore Capital Partners is the latest private equity firm to benefit from the most robust fundraising climate in years, and many have recently closed funds.
The fund, Shore Capital Partners Fund I, was oversubscribed, and will continue the investment strategy of Shore's previous investment vehicles focusing on control buyouts of microcap health care businesses. Targets will have between $1 million and $5 million in Ebitda, and Shore will invest between $10 million and $15 million per platform.
The new fund's investors include pension funds, financial institutions, fund of funds and family offices. Shore Capital will invest in health care services, medical products and consumer-directed health care companies.
Shore Capital, headquartered in Chicago, has invested in Clear Path Diagnostics, Fast Pace Urgent Care Clinic and Quantum Physical Therapy.